Cargando…
A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply
Autores principales: | Cag, Yasemin, Vahaboglu, Haluk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804901/ https://www.ncbi.nlm.nih.gov/pubmed/33439342 http://dx.doi.org/10.1007/s10096-020-04099-w |
Ejemplares similares
-
A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort
por: Cag, Yasemin, et al.
Publicado: (2020) -
A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort
por: Cakir, Banu
Publicado: (2021) -
Authors’ reply
por: Cetinkaya, Servet, et al.
Publicado: (2016) -
An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results
por: Ader, Florence
Publicado: (2022) -
Authors′ reply
por: Grover, A K
Publicado: (2008)